Exelixis (EXEL) Current Deferred Revenue (2010 - 2023)

Exelixis' Current Deferred Revenue history runs 14 years deep, the most recent figure standing at $13.5 million for Q2 2023.

• In Q2 2023, Current Deferred Revenue fell 8.13% year-over-year to $13.5 million; the TTM figure through Jun 2023 stood at $13.5 million (down 8.13% YoY), while the FY2022 annual figure was $14.1 million, down 15.0% from the prior year.
• Current Deferred Revenue for Q2 2023 stood at $13.5 million, up from $13.4 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $19.0 million in Q2 2021, with the low at $321000.0 in Q2 2019.
• The 5-year median for Current Deferred Revenue is $13.8 million (2022), against an average of $12.1 million.
• The sharpest annual moves came in 2019 and 2020: Current Deferred Revenue plunged 94.6% in 2019, then surged 4977.88% in 2020.
• Exelixis' Current Deferred Revenue stood at $8.2 million in 2019, then climbed by 29.27% to $10.6 million in 2020, then soared by 56.16% to $16.6 million in 2021, then slipped by 15.0% to $14.1 million in 2022, then slipped by 3.87% to $13.5 million in 2023.
• Business Quant data shows EXEL's Current Deferred Revenue at $13.5 million in Q2 2023, $13.4 million in Q1 2023, and $14.1 million in Q4 2022.